Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
<b>Background:</b> The use of granulocyte colony-stimulating factors to treat patients with chemotherapy-induced neutropenia is well accepted. To assess whether administration of filgrastim along with standard empiric antibiotic therapy is beneficial for patients with chemotherapy-induce...
Saved in:
| Main Authors: | Advani S, Achreckar Suvarna, Thomas Dennis, Krishnankutty Binny |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2010-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2010;volume=31;issue=3;spage=125;epage=128;aulast=Advani |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipegfilgrastim in patients with chemotherapy-induced neutropenia
by: G. D. Petrova, et al.
Published: (2015-12-01) -
Prevention of neutropenia as an important factor in successful chemotherapy for head and neck cancer
by: L. G. Babicheva, et al.
Published: (2021-11-01) -
Chemotherapy limiting neutropenia. Is prevention required?
by: I. B. Kononenko, et al.
Published: (2022-01-01) -
Effectiveness of filgrastim and polyethylene glycol-filgrastim in the treatment of postchemotherapy neutropenia in children: Phase I clinical trial
by: Saeed Yousofian, et al.
Published: (2019-01-01) -
Factors Associated with Absolute Neutrophil Count Dynamics and Docetaxel-Adryamicin-Cyclophosphamide (TAC) Chemotherapy Induced Neutropenia During Extended Filgrastim Administration in Breast Cancer Patients
by: Ami Ashariati, et al.
Published: (2022-09-01)